Ann: Quarterly Appendix 4C and Activities Report, page-2

News to be released in the near term could be a game changer It was not so long ago that PAA was trading well under 10 cents , hit a 53 cent high this year. DXB was trading well under 10 cents to the high 20 cent range before pulling back to the low 20 cent range at the moment. As I know some will comment regarding how far ahead they are than 1AD.

Look at NYR which was trading at 1.9 cents a few days ago and today hit 17 cents before pulling back to around the 10 cent range . This was mainly based on pre clinical study results not human.

1AD trading in the $10 to $ 12 million market cap is primed here. There is a fair bit of overhead supply up until the mid 2 cent range but could be setting up for a parabolic move forward depending on the quality of update and how well they can sell it to a forward thinking market.